XML 35 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
SHARE-BASED COMPENSATION AND EMPLOYEE BENEFIT PLANS (Tables)
12 Months Ended
Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock Options Activity
A summary of stock option activity under the Plan as of December 31, 2012, and changes during the year ended December 31, 2012 are presented below: 
 
Shares
 
Weighted
Average
Exercise Price
 
Weighted-Average
Remaining
Contractual Term (in yrs)
Outstanding as of January 1, 2012
2,091,005

 
$
6.52

 
 
Granted
727,818

 
2.38

 
 
Forfeited
(1,017,596
)
 
7.75

 
 
Expired
(12,100
)
 
26.22

 
 
Outstanding as of December 31, 2012
1,789,127

 
$
4.00

 
8.33
Vested and exercisable as of December 31, 2012
939,276

 
$
4.81

 
7.82
Vested and expected to vest as of December 31, 2012
1,361,893

 
$
4.06

 
8.24
Schedule of Stock Options, Valuation Assumptions
The assumptions used to determine the value of our stock-based awards under the Black-Scholes method are summarized below:
 
 
2012
 
2011
Risk-free interest rate
0.37% - 1.6%
 
1.0% - 3.0%
Dividend yield
—%
 
—%
Expected volatility
56.8% - 77.9%
 
58.6% - 75.4%
Average expected life in years
5.0
 
5.0
Schedule of Restricted Stock and Restricted Stock Units Award Activity
A summary of restricted stock awards and deferred stock units activity under the Plans as of December 31, 2012, and changes during the year then ended are presented below: 
 
Number of
Restricted Shares and Units
 
Weighted-Average
Grant Date Fair Value
Nonvested balance as of January 1, 2012
85,618

 
$
5.12

Granted
38,126

 
2.07

Vested
(71,370
)
 
3.52

Forfeited
(38,302
)
 
5.47

Nonvested balance as of December 31, 2012
14,072

 
$
4.03

Schedule of Employee Stock Purchase Plan, Valuation Assumptions
The assumptions used to value the shares under the ESPP using the Black-Scholes method were as follows:
 
 
2012
 
2011
Risk-free interest rate
0.02% - 0.10%
 
0.02% - 0.07%
Dividend yield
—%
 
—%
Expected volatility
48.9% - 93.1%
 
33.3% - 56.9%
Expected life in years
3 months
 
3 months